The Board of Directors of ASIT Biotech S.A. appointed Yves Désiront as interim CFO, while the company is looking for a new profile to replace Everard van der Straten, who supervised the financial organization of the company and its financing since its IPO in 2016. Everard van der Straten remains a Board member. Philippe Degeer to join the Board of Directors as representative of Meusinvest.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0226 EUR | 0.00% | -2.59% | -3.83% |
2023 | DMS Imaging SA Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | DMS Imaging SA Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
1st Jan change | Capi. | |
---|---|---|
-3.83% | 36.6M | |
-16.99% | 8.55B | |
+65.23% | 4.24B | |
-1.63% | 2.54B | |
-41.76% | 2.35B | |
-8.53% | 1.89B | |
-19.29% | 1.55B | |
-39.61% | 1.23B | |
+9.54% | 1.13B | |
+19.57% | 955M |
- Stock Market
- Equities
- DMSIM Stock
- News DMS Imaging
- ASIT Biotech S.A. Announces Executive Changes